Soleno Therapeutics Inc Cash Flow Reinvestment Rate
Soleno Therapeutics Inc cash flow reinvestment rate. Soleno Therapeutics Inc (SLNO) has a Cash Flow Reinvestment Rate of 0.00x as of March 2026, reinvesting $40.00K (capex $40.00K ) from operating cash flow of $25.98 Million. Explore Soleno Therapeutics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Soleno Therapeutics Inc (2025–2025)
Cash flow reinvestment rate of Soleno Therapeutics Inc from 2025 to 2025. Historical reinvestment intensity for Soleno Therapeutics Inc across 1 annual periods. Explore Soleno Therapeutics Inc (SLNO) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Soleno Therapeutics Inc Cash Flow Reinvestment Rate by Year (2025–2025)
Soleno Therapeutics Inc cash flow reinvestment rate by year from 2025 to 2025. Year-by-year capital reinvestment analysis for Soleno Therapeutics Inc. For the full cash flow conversion analysis, see how efficiently does Soleno Therapeutics Inc generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 4.31x | $201.78 Million | $46.80 Million | $73.00K | — |